PUBLIC COMPANY
save$RGENREPLIGEN CORP
$RGEN176.89-0.73%Waltham, MA, USupdated 1d ago
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN.
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Insider activity
source: SEC Form 4open-market buys + sells
- Apr 21, 26SELLLoeillot Olivier· Chief Executive Officer−$536K↗
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 59m ago
Found something off?
comments(0)
5-min edit window · permanent after that